Axonics Modulation Technologies has received premarket approval from the Food and Drug Administration (FDA) for Axonics r-SNM System, an implantable sacral neuromodulation device (SMN), for the ...

Dear Dr. Roach: My daughter, who is 50, recently went to a urologist for bladder retention issues. She had several tests performed. My daughter’s doctor told her that the diagnosis is “overactive ...

This x-ray of the pelvis shows an electronic nerve-stimulating device in the right iliac fossa. Over 10 months, complete continence was achieved by approximately half of implanted patients. Real-world ...

New Investigational Device Aims to Expand Access to Therapy for Patients with Incontinence; Underscores Medtronic's Leadership as Only Company to Offer Neuromodulation Options for Incontinence DUBLIN, ...

It's a problem nobody wants to talk about, suffering in silence and embarrassment. Of the 25 million Americans living with incontinence, 80% are women. But a pacemaker for the bladder may be the ...

A minimally invasive, coin-sized implantable device was effective in treating overactive bladder (OAB) syndrome, researchers found. In a prospective, single-arm, open-label study funded by the ...

A 41-year-old nurse from Severance shopping for a solution to her overactive bladder symptoms found a way to regain full control thanks to an innovative procedure. Sarah Avrech said goodbye to a life ...

Inserted near the ankle in a minimally invasive procedure, the device generates low-level electronic impulses that stimulate ...

New research confirms that sacral nerve stimulation is a feasible option for treating subjective symptoms of urinary and fecal incontinence in children. However, owing to a lack of correlation between ...

(RTTNews) - Medtronic plc (MDT) announced FDA approval to proceed with an investigational device exemption trial to evaluate its implantable tibial neuromodulation device — a therapy designed to ...